Chris A. Rallis - 20 Nov 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A. Rallis
Issuer symbol
FENC
Transactions as of
20 Nov 2023
Net transactions value
-$2,219
Form type
4
Filing time
20 Nov 2023, 21:20:08 UTC
Previous filing
18 Aug 2023
Next filing
28 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Sale $2,219 -269 -0.62% $8.25 43,034 20 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 agreement dated March 18, 2022. Sharee sold at a price of $8.25.